Show simple item record

dc.contributor.authorFroux, Lionel
dc.contributor.authorLe Bon-Jego, Morgane
dc.contributor.authorMiguélez Palomo, Cristina
dc.contributor.authorNormand, Elisabeth
dc.contributor.authorMorin, Stephanie
dc.contributor.authorFioramonti, Stéphanie
dc.contributor.authorBarresi, Massimo
dc.contributor.authorFrick, Andreas
dc.contributor.authorBaufreton, Jérôme
dc.contributor.authorTaupignon, Anne
dc.date.accessioned2018-12-10T13:46:59Z
dc.date.available2018-12-10T13:46:59Z
dc.date.issued2018-06-11
dc.identifier.citationScientific Reports 8 : (2018) // Article ID 8858es_ES
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/10810/30225
dc.description.abstractCorticofugal fibers target the subthalamic nucleus (STN), a component nucleus of the basal ganglia, in addition to the striatum, their main input. The cortico-subthalamic, or hyperdirect, pathway, is thought to supplement the cortico-striatal pathways in order to interrupt/change planned actions. To explore the previously unknown properties of the neurons that project to the STN, retrograde and anterograde tools were used to specifically identify them in the motor cortex and selectively stimulate their synapses in the STN. The cortico-subthalamic neurons exhibited very little sag and fired an initial doublet followed by non-adapting action potentials. In the STN, AMPA/kainate synaptic currents had a voltage-dependent conductance, indicative of GluA2-lacking receptors and were partly inhibited by Naspm. AMPA transmission displayed short-term depression, with the exception of a limited bandpass in the 5 to 15 Hz range. AMPA synaptic currents were negatively controlled by dopamine D5 receptors. The reduction in synaptic strength was due to postsynaptic D5 receptors, mediated by a PKA-dependent pathway, but did not involve a modified rectification index. Our data indicated that dopamine, through post-synaptic D5 receptors, limited the cortical drive onto STN neurons in the normal brain.es_ES
dc.description.sponsorshipWe thank Dr. L. Kerkerian Le Goff and Dr. J.L. Lanciego for helpful discussions on our project. We acknowledge the help of Gilles le Pape (AnaStats, Les Vigneaux, France, www.anastats.fr) for statistical analysis of the neurons' intrinsic parameters and input-output curves. We wish to thank Drs Melanie Ginger and Katy Le Corf, for producing the RabV vector, Dr. Sibley (NINDS, Bethesda), who allowed us to use the D5R mutant mice he engineered, as well as Dr. J. Waddington (Royal College of Surgeons, Dublin), who donated the D5R mutant mice we used to generate a colony. Imaging was performed in the Bordeaux Imaging Center, part of the national FranceBioImaging infrastructure. L.F had a PhD funded by MRT, and received a 6-month fellowship from France Parkinson. The Regional Council of Aquitaine and Fondation de France supported this work by grants 12006005 (FCAN scheme), and 2005013850 and 00016810, respectively. France Parkinson supported part of the work (grant no 5293). Financial support was also provided by CNRS, University of Bordeaux, and Labex Brain (ANR-10-LABX-0043).es_ES
dc.language.isoenges_ES
dc.publisherNature Publishinges_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectexternal globus-palliduses_ES
dc.subjectdeep brain-stimulationes_ES
dc.subjectneurons in-vitroes_ES
dc.subjectparkinsons-diseasees_ES
dc.subjectbasal gangliaes_ES
dc.subjectbeta-oscillationses_ES
dc.subjectfunctional specificityes_ES
dc.subjectsynaptic-transmissiones_ES
dc.subjecthyperdirect pathwayes_ES
dc.subjectprefrontal cortexes_ES
dc.titleD5 dopamine receptors control glutamatergic AMPA transmission between the motor cortex and subthalamic nucleuses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.nature.com/articles/s41598-018-27195-6es_ES
dc.identifier.doi10.1038/s41598-018-27195-6
dc.departamentoesFarmacologíaes_ES
dc.departamentoeuFarmakologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's license is described as Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.